Tumor Necrosis Factor α Decreases Glucagon-Like Peptide-2 Expression by Up-Regulating G-Protein–Coupled Receptor 120 in Crohn Disease-Reference-Cited by-同舟云学术

Tumor Necrosis Factor α Decreases Glucagon-Like Peptide-2 Expression by Up-Regulating G-Protein–Coupled Receptor 120 in Crohn Disease

Published:2015-01 Issue:1 Volume:185 Page:185-196
ISSN:0002-9440
Container-title:The American Journal of Pathology
language:en
Short-container-title:The American Journal of Pathology

Author:

Tsukahara Takuya,Watanabe Kenji,Watanabe Toshio,Yamagami Hirokazu,Sogawa Mitsue,Tanigawa Tetsuya,Shiba Masatsugu,Tominaga Kazunari,Fujiwara Yasuhiro,Maeda Kiyoshi,Hirakawa Kosei,Arakawa Tetsuo

Publisher

Elsevier BV

Subject

Pathology and Forensic Medicine

Reference50 articles.

1. A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease;Targan;N Engl J Med,1997

2. Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial;Hanauer;Lancet,2002

3. Effects of glucagon-like peptide 1 on appetite and body weight: focus on the CNS;van Bloemendaal;J Endocrinol,2014

4. The biology of incretin hormones;Drucker;Cell Metab,2006

5. Glucagon-like peptide 1 attenuates the acceleration of gastric emptying induced by hypoglycemia in healthy subjects;Plummer;Diabetes Care,2014

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring Microbial Metabolite Receptors in Inflammatory Bowel Disease: An In Silico Analysis of Their Potential Role in Inflammation and Fibrosis;Pharmaceuticals;2024-04-12

2. Potential role of tirzepatide towards Covid-19 infection in diabetic patients: a perspective approach;Inflammopharmacology;2023-05-19

3. Incretins play an important role in FFA4/GPR120 regulation of glucose metabolism by GW-9508;Life Sciences;2023-04

4. Free fatty acid receptor 4 deletion attenuates colitis by modulating Treg Cells via ZBED6-IL33 pathway;eBioMedicine;2022-06

5. Fatty acids from natural resources in inflammatory gastrointestinal diseases with specific focus on inflammatory bowel disease;Current Advances for Development of Functional Foods Modulating Inflammation and Oxidative Stress;2022